Emily Turton

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial

Solomon Tesfaye, Gordon Sloan, Jennifer Petrie et al. · The Lancet · 2022 · 191 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trial

Christopher Burton, Cara Mooney, Laura Sutton et al. · The Lancet · 2024 · 33 citations · Full text

Nursing, Family Medicine, Physical Therapy +10

Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK

Rebecca L. Gould, Christopher McDermott, Benjamin J. Thompson et al. · The Lancet · 2024 · 32 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +9

The Journeying through Dementia psychosocial intervention versus usual care study: a single-blind, parallel group, phase 3 trial

Gail Mountain, Cindy Cooper, J. Timothy Wright et al. · The Lancet Healthy Longevity · 2022 · 20 citations · Full text

Medicine, Community Health, Geriatric Medicine +16

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial

James O. Lindsay, Daniel Hind, Lizzie Swaby et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 17 citations · Full text

Medicine, Hematology, Immunology +15